Skip to search formSkip to main contentSkip to account menu

Cryptococcus neoformans Ab:Titr:Pt:Ser:Qn:Aggl

Known as: Cryptococcus neoformans As:Titer:Moment:Serum:Kwantitatief:Agglutinatie, Cryptococcus neoformans Ac [Titre] Sérum ; Numérique ; Agglutination, Cryptococcus neoformans Antibody:Dilution Factor (Titer):Point in time:Serum:Quantitative:Agglutination 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
In the present study, the in vitro susceptibility and capsular width from both melanized and non-melanized Cryptococcus… 
2011
2011
Aldimines are aldehyde‐derived compounds that contain a C=N group. Besides its broad industrial applications, this class of non… 
2011
2011
The present work was carried out to study the correlation of capsular size and pathogenicity of C. neoformans in experimentally… 
2009
2009
The human pathogen Cryptococcus neoformans causes meningo-encephalitis. The polysaccharide capsule is one of the main virulence… 
2007
2007
STUDIES OF THE STRUCTURES, BIOSYNTHESIS AND FUNCTION OF FUNGAL GLYCOSPHINGOLIPIDS by Elizabeth A. Owuor University of New… 
2005
2005
Thirty-seven clinical isolates of C. neoformans were recovered from AIDS patients and all were serotype A according to standard… 
2004
2004
In vivo interactions of rabbit alveolar macrophages (AM) and Cryptococcus neoformans, a yeast pathogenic for humans, were studied… 
Highly Cited
1998
Highly Cited
1998
ABSTRACT Mice immunized with two different cryptococcal antigen preparations, one a soluble culture filtrate antigen (CneF) in…